Related Experiment Video
Updated: May 13, 2026
09:45
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Polymeric nanocarriers for subcellular targeting in photodynamic therapy
Ieda Vieira da Cunha1, Isabela Lopes E Cytrângolo1, Maurício S Baptista2
1Institute of Chemistry, Federal University of Uberlandia, Uberlandia, Minas Gerais, Brazil.
Summary
Photodynamic therapy (PDT) efficacy relies on photosensitizer (PS) organelle targeting, not just reactive species. Advanced polymeric nanocarriers enhance PS delivery for improved therapeutic selectivity and outcomes.
Area of Science:
- Nanomedicine
- Photobiology
- Polymer Science
Background:
- Photodynamic therapy (PDT) is an established cancer treatment, but its efficacy is limited by empirical protocols.
- Subcellular localization of photosensitizers (PSs) significantly impacts cell death efficiency, more than reactive species generation.
- Targeting PSs to specific organelles like mitochondria and lysosomes is crucial for enhancing therapeutic selectivity.
Purpose of the Study:
- To provide a comprehensive overview of advanced polymeric nanocarriers for subcellular targeting in PDT.
- To examine the role of nanoplatforms as protective carriers and active targeting agents for PSs.
- To critically assess the therapeutic potential and challenges of organelle-specific targeting to optimize efficacy and reduce toxicity.
Main Methods:
- Review of literature on polymeric nanocarriers for PDT.
- Analysis of nanocarrier design principles for subcellular localization.
- Evaluation of stability, biocompatibility, and modularity of nanoplatforms.
Main Results:
- Polymeric nanocarriers offer enhanced stability, biocompatibility, and modularity for PS delivery.
- Engineered nanocarriers enable precise targeting of vital organelles, improving PDT selectivity.
- Successful organelle targeting can significantly enhance the efficacy-to-toxicity ratio.
Conclusions:
- Polymer science integration with photobiology and nanomedicine offers a rational approach to developing superior PDT treatments.
- Subcellular targeting using advanced nanocarriers represents a promising frontier for optimizing PDT.
- Further research into organelle-specific targeting strategies is essential for clinical advancement.
Keywords:
Endoplasmic reticulumLysosomesMitochondriaPhotodynamic therapyPolymeric nanocarrierSubcellular targetingMore Related Videos
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.